.jpg)
.png)
NLA News
JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical Communications, LLC (Paradigm), a multiple award-winning medical education company, are proud to announce their... more
By Carl E. Orringer A 55-year-old South Asian Indian physician comes to you for management recommendations for primary prevention of atherosclerotic cardiovascular disease (ASCVD). He has no current cardiovascular symptoms. He has an eight-year history of well-controlled arterial hypertension... more
The National Lipid Association (NLA), in collaboration with the American Society for Preventive Cardiology (ASPC), has released a Joint Expert Clinical Consensus providing new guidance on the recognition and management of persistent chylomicronemia — a severe and often misunderstood form of... more
The National Lipid Association (NLA) is committed to enhancing the practice of lipid management in clinical medicine. A major component is having access to all therapies to properly treat patients with the management of lipid disorders. PCSK9 inhibitors are one therapy that patients have... more
SILVER SPRING, Md. – National Lipid Association Board Member Lori Alexander, MSHS, RD, CCRC, CLS, FNLA testified on Thursday, May 10 in front of the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee on behalf of familial chylomicronemia patients. The... more
The National Lipid Association would like to extend its congratulations to all of our Fellows of the NLA, current and past, honored at the 2023 National Lipid Association Honors & Awards Ceremony earlier this month: Cindy L. Bredefeld, DO, FNLA Jaime Burkle,... more
The NLA Recommendations for Patient-Centered Management of Dyslipidemia was recently published in the Journal of Clinical Lipidology. As you know, these Recommendations are a tool for clinicians who treat patients with dyslipidemia — and they should serve as guidance for treatment. To... more
The National Lipid Association (NLA) has released a comprehensive clinical review titled “Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association.” This new guidance provides an in-depth examination of the diagnosis, management, and treatment landscape for... more
Are you active on Twitter? If so, the NLA (@nationallipid) would like to invite you to join us on Wednesday, September 23 at 7 pm ET, for our first ever #NLAchat! What is a Twitter chat? A tweet chat is a live Twitter conversation, focused on a topic and moderated by a host. To... more